These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31921870)

  • 1. Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms.
    Roy S; Glaser S; Chakraborty S
    Front Med (Lausanne); 2019; 6():293. PubMed ID: 31921870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium.
    Gentilini A; Pastore M; Marra F; Raggi C
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma.
    Tamma R; Annese T; Ruggieri S; Brunetti O; Longo V; Cascardi E; Mastropasqua MG; Maiorano E; Silvestris N; Ribatti D
    Eur J Clin Invest; 2019 May; 49(5):e13087. PubMed ID: 30767196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine.
    Rimassa L; Personeni N; Aghemo A; Lleo A
    J Autoimmun; 2019 Jun; 100():17-26. PubMed ID: 30862450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Chemokines in the Biology of Cholangiocarcinoma.
    Caligiuri A; Pastore M; Lori G; Raggi C; Di Maira G; Marra F; Gentilini A
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF21 inhibits tumor-associated angiogenesis and suppresses the growth of cholangiocarcinoma by targeting PI3K/Akt and ERK signaling.
    Duan HX; Li BW; Zhuang X; Wang LT; Cao Q; Tan LH; Qu GF; Xiao S
    Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G763-G773. PubMed ID: 30920845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes.
    Li C; Bie L; Chen M; Ying J
    Explor Target Antitumor Ther; 2023; 4(6):1310-1327. PubMed ID: 38213535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
    Wu HJ; Chu PY
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target.
    Zhou M; Wang C; Lu S; Xu Y; Li Z; Jiang H; Ma Y
    EBioMedicine; 2021 May; 67():103375. PubMed ID: 33993051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?
    Romano M; De Francesco F; Gringeri E; Giordano A; Ferraro GA; Di Domenico M; Cillo U
    J Cell Physiol; 2016 Apr; 231(4):768-76. PubMed ID: 26357947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma.
    Voigtländer T; Metzger J; Husi H; Kirstein MM; Pejchinovski M; Latosinska A; Frantzi M; Mullen W; Book T; Mischak H; Manns MP
    J Biomed Sci; 2020 Jan; 27(1):13. PubMed ID: 31900160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.
    Merino-Azpitarte M; Lozano E; Perugorria MJ; Esparza-Baquer A; Erice O; Santos-Laso Á; O'Rourke CJ; Andersen JB; Jiménez-Agüero R; Lacasta A; D'Amato M; Briz Ó; Jalan-Sakrikar N; Huebert RC; Thelen KM; Gradilone SA; Aransay AM; Lavín JL; Fernández-Barrena MG; Matheu A; Marzioni M; Gores GJ; Bujanda L; Marin JJG; Banales JM
    J Hepatol; 2017 Jul; 67(1):72-83. PubMed ID: 28237397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUG CCArly: A Novel Autologous 3D Cholangiocarcinoma Model Presents an Increased Angiogenic Potential.
    Schrom S; Kleinegger F; Anders I; Hebesberger T; Karner C; Liesinger L; Birner-Gruenberger R; Renner W; Pichler M; Grillari R; Aigelsreiter A; Rinner B
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
    Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
    Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma.
    Yeh CN; Maitra A; Lee KF; Jan YY; Chen MF
    Carcinogenesis; 2004 Apr; 25(4):631-6. PubMed ID: 14656942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of CD44 in bile duct cancer correlates with poor prognosis.
    Kunlabut K; Vaeteewoottacharn K; Wongkham C; Khuntikeo N; Waraasawapati S; Pairojkul C; Wongkham S
    Asian Pac J Cancer Prev; 2012; 13 Suppl():95-9. PubMed ID: 23480770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.
    Brivio S; Cadamuro M; Strazzabosco M; Fabris L
    World J Hepatol; 2017 Mar; 9(9):455-468. PubMed ID: 28396716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells in inflammatory microenvironment potently promote metastatic growth of cholangiocarcinoma
    Zhong W; Tong Y; Li Y; Yuan J; Hu S; Hu T; Song G
    Oncotarget; 2017 Sep; 8(43):73693-73704. PubMed ID: 29088737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma, gone without the Wnt?
    Noll AT; Cramer T; Olde Damink SW; Schaap FG
    World J Hepatol; 2016 Sep; 8(26):1093-6. PubMed ID: 27660676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.